Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan.
Int J Hematol
; 109(3): 336-345, 2019 Mar.
Article
in En
| MEDLINE
| ID: mdl-30604312
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Product Surveillance, Postmarketing
/
Hemostatics
/
Blood Coagulation Factor Inhibitors
/
Hemophilia A
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Hematol
Journal subject:
HEMATOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: